In a stunning display of the medical establishment actually doing its job for once, three Ebola vaccines are currently being developed amidst fresh outbreak fears. The UK, ever the gentleman in the face of apocalyptic plagues, has thrown its financial weight behind the trials. But let's not get too excited, dear reader, because if history has taught us anything it is that vaccines are developed with the same bureaucratic urgency as a council deciding on a new roundabout.
Ebola, the virus that makes the common cold look like a polite cough, has once again reared its haemorrhagic head in the Democratic Republic of Congo. The World Health Organisation, that marvellous orchestra of red tape and good intentions, has declared it a public health emergency of international concern. Cue the panicked headlines, the stockpiling of hand sanitiser, and the inevitable conspiracy theories that the whole thing is a plot to inject us with microscopic tracking devices.
But fear not! The UK Vaccine Network, a consortium of scientists who probably haven't seen daylight since the Blair administration, is funding the development of three separate vaccines. Yes, three. Because one vaccine for a disease that kills half its victims is simply not enough. We must have options. Variety is the spice of life, or in this case, the spice of not dying in a pool of your own bodily fluids.
Let’s take a moment to appreciate the names: ChAdOx1, MVA-BN-Filo, and something called a “pan-ebola” vaccine that sounds like it should be served with a side of pita bread. These are not just vaccines; they are a promise of salvation wrapped in acronyms and clinical trial data. The British government has pledged £6 million to the cause, which is roughly the same amount they spend on paperclips for the Department of Health, but let’s not be cynical.
The trials will involve our brave volunteers, who I imagine are either altruistic saints or people who have mistaken the consent form for a free trip to the Bahamas. They will be injected with the vaccine and then exposed to a weakened form of the virus. It’s a bit like playing Russian roulette but with science. Actually, it’s exactly like that.
But here is the kicker: even if these vaccines prove effective, the real battle is not against the virus but against the systems that allow it to spread. Ebola thrives in poverty, in conflict zones, in places where healthcare is a luxury and clean water is a dream. The vaccines are a plaster on a gaping wound, a band-aid on a bullet hole. But hey, at least we’ll have something to show for our panic.
The real story here is not the science but the theatre. The press releases, the photo ops of white-coated researchers looking determined, the solemn promises from politicians who wouldn’t know a pipette from a paper straw. It is a grand performance designed to convince us that someone, somewhere, is in control. And we, the audience, buy tickets every time.
So let us raise a glass of gin, lukewarm and aeroplane-sized, to the three vaccines. May they work better than the last round of funding for early childhood education. And if they fail, well, there is always the fourth vaccine just around the corner. Because the only thing more resilient than the human spirit is the medical industry’s ability to produce hope from a test tube.
In the meantime, I will be over here, perfecting my own home remedy: a stiff drink and a healthy dose of denial. It has not failed me yet.
